Global Blood Plasma Fractionation Sales Market Report 2024
The global Blood Plasma Fractionation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Segment by Application
Immunity
Therapy
Surgery
The Blood Plasma Fractionation market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Blood Plasma Fractionation market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
GE Healthcare
Pall Corporation
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Table of Content
1 Blood Plasma Fractionation Market Overview
1.1 Blood Plasma Fractionation Product Scope
1.2 Blood Plasma Fractionation Segment by Type
1.2.1 Global Blood Plasma Fractionation Sales by Type (2016 & 2021 & 2027)
1.2.2 Albumin
1.2.3 Immune Globulin
1.2.4 Coagulation Factor
1.3 Blood Plasma Fractionation Segment by Application
1.3.1 Global Blood Plasma Fractionation Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Immunity
1.3.3 Therapy
1.3.4 Surgery
1.4 Blood Plasma Fractionation Market Estimates and Forecasts (2016-2027)
1.4.1 Global Blood Plasma Fractionation Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Blood Plasma Fractionation Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Blood Plasma Fractionation Price Trends (2016-2027)
2 Blood Plasma Fractionation Estimates and Forecasts by Region
2.1 Global Blood Plasma Fractionation Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Blood Plasma Fractionation Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Blood Plasma Fractionation Sales Market Share by Region (2016-2021)
2.2.2 Global Blood Plasma Fractionation Revenue Market Share by Region (2016-2021)
2.3 Global Blood Plasma Fractionation Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Blood Plasma Fractionation Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Blood Plasma Fractionation Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Blood Plasma Fractionation Estimates and Projections (2016-2027)
2.4.2 Europe Blood Plasma Fractionation Estimates and Projections (2016-2027)
2.4.3 China Blood Plasma Fractionation Estimates and Projections (2016-2027)
2.4.4 Japan Blood Plasma Fractionation Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Blood Plasma Fractionation Estimates and Projections (2016-2027)
2.4.6 India Blood Plasma Fractionation Estimates and Projections (2016-2027)
3 Global Blood Plasma Fractionation Competition Landscape by Players
3.1 Global Top Blood Plasma Fractionation Players by Sales (2016-2021)
3.2 Global Top Blood Plasma Fractionation Players by Revenue (2016-2021)
3.3 Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020)
3.4 Global Blood Plasma Fractionation Average Price by Company (2016-2021)
3.5 Manufacturers Blood Plasma Fractionation Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Blood Plasma Fractionation Market Size by Type
4.1 Global Blood Plasma Fractionation Historic Market Review by Type (2016-2021)
4.1.1 Global Blood Plasma Fractionation Sales Market Share by Type (2016-2021)
4.1.2 Global Blood Plasma Fractionation Revenue Market Share by Type (2016-2021)
4.1.3 Global Blood Plasma Fractionation Price by Type (2016-2021)
4.2 Global Blood Plasma Fractionation Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Blood Plasma Fractionation Sales Forecast by Type (2022-2027)
4.2.2 Global Blood Plasma Fractionation Revenue Forecast by Type (2022-2027)
4.2.3 Global Blood Plasma Fractionation Price Forecast by Type (2022-2027)
5 Global Blood Plasma Fractionation Market Size by Application
5.1 Global Blood Plasma Fractionation Historic Market Review by Application (2016-2021)
5.1.1 Global Blood Plasma Fractionation Sales Market Share by Application (2016-2021)
5.1.2 Global Blood Plasma Fractionation Revenue Market Share by Application (2016-2021)
5.1.3 Global Blood Plasma Fractionation Price by Application (2016-2021)
5.2 Global Blood Plasma Fractionation Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Blood Plasma Fractionation Sales Forecast by Application (2022-2027)
5.2.2 Global Blood Plasma Fractionation Revenue Forecast by Application (2022-2027)
5.2.3 Global Blood Plasma Fractionation Price Forecast by Application (2022-2027)
6 North America Blood Plasma Fractionation Market Facts & Figures
6.1 North America Blood Plasma Fractionation Sales by Company
6.1.1 North America Blood Plasma Fractionation Sales by Company (2016-2021)
6.1.2 North America Blood Plasma Fractionation Revenue by Company (2016-2021)
6.2 North America Blood Plasma Fractionation Sales Breakdown by Type
6.2.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
6.2.2 North America Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
6.3 North America Blood Plasma Fractionation Sales Breakdown by Application
6.3.1 North America Blood Plasma Fractionation Sales Breakdown by Application (2016-2021)
6.3.2 North America Blood Plasma Fractionation Sales Breakdown by Application (2022-2027)
7 Europe Blood Plasma Fractionation Market Facts & Figures
7.1 Europe Blood Plasma Fractionation Sales by Company
7.1.1 Europe Blood Plasma Fractionation Sales by Company (2016-2021)
7.1.2 Europe Blood Plasma Fractionation Revenue by Company (2016-2021)
7.2 Europe Blood Plasma Fractionation Sales Breakdown by Type
7.2.1 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
7.2.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
7.3 Europe Blood Plasma Fractionation Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Blood Plasma Fractionation Market Facts & Figures
8.1 China Blood Plasma Fractionation Sales by Company
8.1.1 China Blood Plasma Fractionation Sales by Company (2016-2021)
8.1.2 China Blood Plasma Fractionation Revenue by Company (2016-2021)
8.2 China Blood Plasma Fractionation Sales Breakdown by Type
8.2.1 China Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
8.2.2 China Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
8.3 China Blood Plasma Fractionation Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)
9 Japan Blood Plasma Fractionation Market Facts & Figures
9.1 Japan Blood Plasma Fractionation Sales by Company
9.1.1 Japan Blood Plasma Fractionation Sales by Company (2016-2021)
9.1.2 Japan Blood Plasma Fractionation Revenue by Company (2016-2021)
9.2 Japan Blood Plasma Fractionation Sales Breakdown by Type
9.2.1 Japan Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
9.2.2 Japan Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
9.3 Japan Blood Plasma Fractionation Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Blood Plasma Fractionation Market Facts & Figures
10.1 Southeast Asia Blood Plasma Fractionation Sales by Company
10.1.1 Southeast Asia Blood Plasma Fractionation Sales by Company (2016-2021)
10.1.2 Southeast Asia Blood Plasma Fractionation Revenue by Company (2016-2021)
10.2 Southeast Asia Blood Plasma Fractionation Sales Breakdown by Type
10.2.1 Southeast Asia Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Blood Plasma Fractionation Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Blood Plasma Fractionation Market Facts & Figures
11.1 India Blood Plasma Fractionation Sales by Company
11.1.1 India Blood Plasma Fractionation Sales by Company (2016-2021)
11.1.2 India Blood Plasma Fractionation Revenue by Company (2016-2021)
11.2 India Blood Plasma Fractionation Sales Breakdown by Type
11.2.1 India Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
11.2.2 India Blood Plasma Fractionation Sales Breakdown by Type (2022-2027)
11.3 India Blood Plasma Fractionation Sales Breakdown by Application
11.3.1 India Blood Plasma Fractionation Sales Breakdown by Application (2016-2021)
11.3.2 India Blood Plasma Fractionation Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Blood Plasma Fractionation Business
12.1 GE Healthcare
12.1.1 GE Healthcare Corporation Information
12.1.2 GE Healthcare Business Overview
12.1.3 GE Healthcare Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GE Healthcare Blood Plasma Fractionation Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Pall Corporation
12.2.1 Pall Corporation Corporation Information
12.2.2 Pall Corporation Business Overview
12.2.3 Pall Corporation Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pall Corporation Blood Plasma Fractionation Products Offered
12.2.5 Pall Corporation Recent Development
12.3 Baxter
12.3.1 Baxter Corporation Information
12.3.2 Baxter Business Overview
12.3.3 Baxter Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter Blood Plasma Fractionation Products Offered
12.3.5 Baxter Recent Development
12.4 CSL
12.4.1 CSL Corporation Information
12.4.2 CSL Business Overview
12.4.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CSL Blood Plasma Fractionation Products Offered
12.4.5 CSL Recent Development
12.5 Grifols
12.5.1 Grifols Corporation Information
12.5.2 Grifols Business Overview
12.5.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Grifols Blood Plasma Fractionation Products Offered
12.5.5 Grifols Recent Development
12.6 Octapharma
12.6.1 Octapharma Corporation Information
12.6.2 Octapharma Business Overview
12.6.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Octapharma Blood Plasma Fractionation Products Offered
12.6.5 Octapharma Recent Development
12.7 BPL
12.7.1 BPL Corporation Information
12.7.2 BPL Business Overview
12.7.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 BPL Blood Plasma Fractionation Products Offered
12.7.5 BPL Recent Development
12.8 Kedrion
12.8.1 Kedrion Corporation Information
12.8.2 Kedrion Business Overview
12.8.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Kedrion Blood Plasma Fractionation Products Offered
12.8.5 Kedrion Recent Development
12.9 Mitsubishi Tanabe
12.9.1 Mitsubishi Tanabe Corporation Information
12.9.2 Mitsubishi Tanabe Business Overview
12.9.3 Mitsubishi Tanabe Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mitsubishi Tanabe Blood Plasma Fractionation Products Offered
12.9.5 Mitsubishi Tanabe Recent Development
12.10 CBOP
12.10.1 CBOP Corporation Information
12.10.2 CBOP Business Overview
12.10.3 CBOP Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CBOP Blood Plasma Fractionation Products Offered
12.10.5 CBOP Recent Development
12.11 RAAS
12.11.1 RAAS Corporation Information
12.11.2 RAAS Business Overview
12.11.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.11.4 RAAS Blood Plasma Fractionation Products Offered
12.11.5 RAAS Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Corporation Information
12.12.2 Hualan Bio Business Overview
12.12.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hualan Bio Blood Plasma Fractionation Products Offered
12.12.5 Hualan Bio Recent Development
13 Blood Plasma Fractionation Manufacturing Cost Analysis
13.1 Blood Plasma Fractionation Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Blood Plasma Fractionation
13.4 Blood Plasma Fractionation Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Blood Plasma Fractionation Distributors List
14.3 Blood Plasma Fractionation Customers
15 Market Dynamics
15.1 Blood Plasma Fractionation Market Trends
15.2 Blood Plasma Fractionation Drivers
15.3 Blood Plasma Fractionation Market Challenges
15.4 Blood Plasma Fractionation Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer